ÌÇÐÄÊÓÆµ

Michael M Ittmann

Ittmann

Michael M Ittmann, M.D., Ph.D.

Professor

(713) 798-6196

Positions

Professor
Pathology
ÌÇÐÄÊÓÆµ of Medicine
Houston, TX, US
William D. Tigertt Chair in Pathology
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Co-Leader, Cancer Biology Program
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Director, Human Tissue Acquisition & Pathology Shared Resource
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States

Addresses

BCM-Ben Taub Research Center (Lab)
Room: BCMT-T221
Houston, TX, 77030
United States
BCM-Ben Taub Research Center (Office)
Room: BCMT-T221
Houston, TX, 77030
United States

Education

B.S. from Michigan State University
01/1976 - East Lansing, MI, United States
Ph.D. from Case Western Reserve University
01/1982 - Cleveland, OH, United States
Advanced Training from New York University Medical Center
01/1984 - New York, NY, United States
M.D. from Case Western Reserve University
01/1983 - Cleveland, OH, United States
Advanced Training from New York University
01/1987 - New York, NY, United States
Advanced Training from New York University Medical Center
01/1985 - New York, NY, United States

Certifications

Physician
#K6016 (02/28/2020 - 02/28/2022)
Texas Medical Board

Professional Interests

  • Molecular genetics of prostate cancer
  • Fibroblast growth factors
  • Benign Prostatic Hyperplasia

Websites

Selected Publications

  • Yang F, Zhang Y, Ressler SJ, Ittmann MM, Ayala GE, Dang TD, Wang F, Rowley DR. " " Cancer Res.. 2013 Apr 10;
    Pubmed PMID: .
  • Feng S, Dakhova O, Creighton CJ, Ittmann M. " " Cancer Res.. 2013 Apr 15; 73 (8) : 2551-62.
    Pubmed PMID: .
  • Qin J, Wu SP, Creighton CJ, Dai F, Xie X, Cheng CM, Frolov A, Ayala G, Lin X, Feng XH, Ittmann MM, Tsai SJ, Tsai MJ, Tsai SY. " " Nature. 2013 Jan 10; 493 (7431) : 236-40.
    Pubmed PMID: .
  • Shao L, Tekedereli I, Wang J, Yuca E, Tsang S, Sood A, Lopez-Berestein G, Ozpolat B, Ittmann M. " " Clin. Cancer Res.. 2012 Dec 15; 18 (24) : 6648-57.
    Pubmed PMID: .

Funding

Enhancing outcomes of radiation therapy for prostate cancer
$982,000.00   (10/01/2018 - 09/30/2021)
Grant funding from DOD Prostate Cancer Program
The goal of this proposal is to examine the impact of inhibition of RET and/or FGFR kinases on radiation therapy in prostate cancer
Tumor microenvironment-based biomarkers in African American prostate cancer
#PC170374
$471,000.00   (10/01/2018 - 09/30/2021)
Grant funding from DOD Prostate Cancer Program
The goal of this proposal is to evaluate reactive stroma biomarkers in African American prostate cancer.
A Novel Oncogenic Axis in African American Prostate Cancer
$500,000.00   (04/01/2019 - 03/31/2023)
Grant funding from Dept of Veterans Affairs
The goal of this project is to characterize the role of RGS12 in African American prostate cancer.

to edit your profile